Table 4.

Post-transplant time-to-event and recurrent outcomes for liver and simultaneous liver-kidney recipients by donor HIV status, after weighting.

Outcomes	Estimate (95% CI)	p-value
Time-to-event
Mortality, wHR	6.55 (1.11-38.60)	0.04
Cancer, wHR	7.34 (1.48-36.39)	0.02
Recurrent events
Rejection episodes, wIRR	0.91 (0.19-4.23)	0.90
IR HIV D+/R+ (per 100 person-years)	15.3 (6.3-37.2)
IR HIV D−/R+ (per 100 person years)	16.8 (5.0-56.2)
SAEs, wIRR	1.60 (0.83-3.06)	0.16
IR HIV D+/R+ (per 100 person-years)	188.6 (118.1-301.1)
IR HIV D−/R+ (per 100 person years)	118.2 (75.0-186.3)
Infectious hospitalization, wIRR	4.25 (1.43-12.62)	0.009
IR HIV D+/R+ (per 100 person-years)	73.8 (39.0-139.9)
IR HIV D−/R+ (per 100 person years)	17.4 (7.3-41.1)
Opportunistic infection, wIRR	5.37 (1.32-21.83)	0.02
IR HIV D+/R+ (per 100 person-years)	20.8 (8.8-48.8)
IR HIV D−/R+ (per 100 person years)	3.9 (1.3-11.8)
HIV breakthrough, wIRR	0.90 (0.12-6.58)	0.92
IR HIV D+/R+ (per 100 person-years)	4.2 (1.1-16.3)
IR HIV D−/R+ (per 100 person years)	4.7 (1.1-19.5)

CI, confidence interval; IR, incidence rate; SAE, serious adverse event; wHR, weighted hazard ratio; wIRR, weighted incidence rate ratio.